Persea Americana for Total Health (PATH)-2

计划入组 45 人 · 首次发布于 2023 年 7 月 12 日

Persea Americana for Total Health (PATH ) Study

计划入组 200 人 · 首次发布于 2016 年 4 月 15 日

PERmixon® in LUTS Evaluation Study (PERLES)

计划入组 833 人 · 首次发布于 2014 年 4 月 23 日

HER2ea-HER2eb-HER2ec

PERPER YAKOV MD

United States

PERHA PHARMACEUTICALS

France

Perle Bioscience, Inc.

United States

Hetero Healthcare and Enzene Launch Perzea, India's Most Affordable Pertuzumab Biosimilar for HER2-Positive Breast Cancer

Ashland launches permexa™ sodium caprate to advance oral biologics delivery

FDA Approves First Perjeta Biosimilar as Shanghai Henlius and Organon Secure Interchangeable Status